Top Tweets for #proc
OK......I think the sheer volume of waste is something #PROC (or the like) should take a look at.
This is an absurd waste of productivity and resources when we can afford neither and it was all for the effect of THIS post and nothing more. There needs to be penalty for stunts
BREAKING
The Liberals have voted AGAINST our common sense opposition motion calling on the Liberal Prime Minister to immediately present a plan to reverse all the economic policies of the Liberal government which have given Canada the G7s WORST economy.
While in New York, Carney said that, “a country that can’t feed, fuel or defend itself is not truly sovereign.” Yet that’s exactly the reality facing Canadians today: millions relying on food banks, tens of thousands out of work, and the only shrinking economy in the G7.
The Liberal government needs to reverse course now. It’s time for the Prime Minister to present a plan.
Les rapports suivants ont été présentés par @CdcComites dans la #Cdc : #BCAN, #PROC
Ils seront disponibles sous peu : https://t.co/v9LNVPyqPj
Reports were presented from @HoCCommittees in the #HoC: #BCAN, #PROC
They will be available online shortly: https://t.co/HvfHlygec0
My #ASCO26 #OvarianCancer recap PART 2.
One approval incoming. One negative trial. And an ADC pipeline that just got very crowded.
Platinum-resistant ovarian cancer (#PROC) #ROSELLA taxane subgroup answered the most common clinical hesitation: OS benefit holds even if your patient got taxane last. HR 0.67 in patients who received taxane most recently. HR 0.60 with taxane-free interval 6 months or less. No biomarker selection required.
FDA PDUFA July 11. Relacorilant is coming to your clinic. Know it now.
The mechanism matters here. Relacorilant blocks the glucocorticoid receptor. GR activation drives taxane resistance. The biology explains the subgroup consistency.
The setback #MIROVA missed. Mirvetuximab + carboplatin did not improve outcomes in platinum-sensitive FRα-high disease. Mirvetuximab stays in PROC. Indication expansion did not hold.
The pipeline Three new ADC programs in PROC presented this week alone.
#TUB040: NaPi2b target, exatecan payload, phase 1 dose escalation (NAPISTAR 1-01) #TemabA: cMet ADC, AbbVie, activity in unselected AND cMet-selected PROC #PuxiSam: B7-H4 ADC, responses in ovarian cohort alongside EC data
FRα. NaPi2b. cMet. B7-H4. Four targets. Multiple payloads. One disease.
Sequencing is going to be the next hard problem in PROC. We do not have that answer yet.
My clinical take for tomorrow in clinic:
Platinum-resistant patient who already got taxane and you have been hesitating on relacorilant: stop hesitating. The subgroup data were built for exactly that patient.
Know your FRα status on every PROC patient at diagnosis. Know your cMet and B7-H4 status by the time they hit second or third line. Trials are open now and the targets are actionable.
If your patient has progressed on mirvetuximab in PROC, there is no approved next step. Get them on a trial. TUB-040, TemabA, and PuxiSam are all enrolling.
#ASCO2026 #OvarianCancer #GynOnc #ADC #PROC
@NRGonc @OncoAlert
Lo que te rompió no te destruyó #ReflexiónDiaria #DiosHablaHoy #Fe #Proc... https://t.co/J3CD8vObiU vía @YouTube
Les rapports suivants ont été présentés par @CdcComites dans la #Cdc : #PROC, #JUST
Ils seront disponibles sous peu : https://t.co/v9LNVPyqPj
Reports were presented from @HoCCommittees in the #HoC: #PROC, #JUST
They will be available online shortly: https://t.co/HvfHlygec0
Monday Market Update (6/1): NatGas jumped nearly 6% to a ~2.5-month high ($3.42/MMBtu on Nymex) on hotter June forecasts + tight storage.
Want to track the impact on your bills? Energy Tracker Pro + contract strategy: $0 out of pocket.
#EnergyConsulting #NaturalGas #Proc
Interpretación trascendental d lo sociopolíticoeconómico. Reunión 1 junio 2026 #Trabajo #Economía #Vivienda #MENSAJE #Educación #EvoluciónSerHumano #Proc... @ivoox https://t.co/jTjMBcMt8C
Can't stop talking about the huge step we are taking in #PROC treatment. A population that didn’t really have effective treatment for before, and here we go! Now we have 3 options! Look at the curves! #ovariancancer #gynonc #ASCO2026 Now the choice will be based on markers and personalized treatment. @ocrahope
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.1M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.1M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.5M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.1M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers